All Outputs (4)

Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England (2024)
Journal Article
Copland, E., Patone, M., Saatci, D., Handunnetthi, L., Hirst, J., Hunt, D. P. J., Mills, N. L., Moss, P., Sheikh, A., Coupland, C. A., Harnden, A., Robertson, C., & Hippisley-Cox, J. (2024). Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England. Nature Communications, 15(1), Article 3822. https://doi.org/10.1038/s41467-024-47745-z

The risk-benefit profile of COVID-19 vaccination in children remains uncertain. A self-controlled case-series study was conducted using linked data of 5.1 million children in England to compare risks of hospitalisation from vaccine safety outcomes af... Read More about Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England.

Expert assessment of future vulnerability of the global peatland carbon sink (2020)
Journal Article
Loisel, J., Gallego-Sala, A. V., Amesbury, M. J., Magnan, G., Anshari, G., Beilman, D. W., Benavides, J. C., Blewett, J., Camill, P., Charman, D. J., Chawchai, S., Hedgpeth, A., Kleinen, T., Korhola, A., Large, D., Mansilla, C. A., Müller, J., van Bellen, S., West, J. B., Yu, Z., …Wu, J. (2020). Expert assessment of future vulnerability of the global peatland carbon sink. Nature Climate Change, https://doi.org/10.1038/s41558-020-00944-0

© 2020, The Author(s), under exclusive licence to Springer Nature Limited. The carbon balance of peatlands is predicted to shift from a sink to a source this century. However, peatland ecosystems are still omitted from the main Earth system models th... Read More about Expert assessment of future vulnerability of the global peatland carbon sink.

Cytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemia (2016)
Journal Article
Parry, H. M., Damery, S., Hudson, C., Maurer, M. J., Cerhan, J. R., Pachnio, A., Begum, J., Slager, S. L., Fegan, C., Man, S., Pepper, C., Shanafelt, T. D., Pratt, G., & Moss, P. A. (2016). Cytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemia. American Journal of Hematology, 91(8), https://doi.org/10.1002/ajh.24403

Human cytomegalovirus (HCMV) is a widely prevalent herpes virus which establishes a state of chronic infection. The establishment of CMV-specific immunity controls viral reactivation and leads to the accumulation of very large numbers of virus-specif... Read More about Cytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemia.

Poor functional antibody responses are present in nearly all patients with chronic lymphocytic leukaemia, irrespective of total IgG concentration, and are associated with increased risk of infection (2015)
Journal Article
Parry, H. M., Birtwistle, J., Whitelegg, A., Hudson, C. D., McSkeane, T., Hazlewood, P., Mudongo, N., Pratt, G., Moss, P., Drayson, M. T., Murray, J., & Richter, A. G. (in press). Poor functional antibody responses are present in nearly all patients with chronic lymphocytic leukaemia, irrespective of total IgG concentration, and are associated with increased risk of infection. British Journal of Haematology, 171(5), https://doi.org/10.1111/bjh.13455